Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Severe enterovirus infections in patients with immune-mediated inflammatory diseases receiving anti-CD20 monoclonal antibodies.
Martin de Frémont G, Chabrolles H, Mirand A, L'Honneur AS, Mélé N, Dunogue B, Boutboul D, Farhat M, Hachulla E, Lazrek M, Rieu V, Mathian A, Chaussade H, Ruet A, Burrel S, Coury-Lucas F, Schuffenecker I, Lemaignen A, Stefic K, le Besnerais M, Carrette M, Mouthon L, Avettand-Fenoel V, Terrier B, Hadjadj J. Martin de Frémont G, et al. RMD Open. 2024 May 20;10(2):e004036. doi: 10.1136/rmdopen-2023-004036. RMD Open. 2024. PMID: 38772678 Free article.
[New section: "The journal's portraits"].
Roeser A, Martin de Frémont G, Chevalier K. Roeser A, et al. Among authors: martin de fremont g. Rev Med Interne. 2024 Apr;45(4):186. doi: 10.1016/j.revmed.2024.03.010. Epub 2024 Apr 4. Rev Med Interne. 2024. PMID: 38575439 French. No abstract available.
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.
Siempos II, Kalil AC, Belhadi D, Veiga VC, Cavalcanti AB, Branch-Elliman W, Papoutsi E, Gkirgkiris K, Xixi NA, Kotanidou A, Hermine O, Porcher R, Mariette X; CORIMUNO-19 Collaborative Group; DisCoVeRy Study Group; ACTT-2 Study Group; ACTT-3 Study Group. Siempos II, et al. EClinicalMedicine. 2024 Feb 9;69:102472. doi: 10.1016/j.eclinm.2024.102472. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38361992 Free PMC article.
Reply to Zhou et al. 'A novel approach for characterization of KSHV-associated multicentric Castleman disease from effusions'.
Vanjak A, Garzaro M, Knapp S, Silvestrini MA, Martin de Fremont G, Bertinchamp R, Calvani J, Meignin V, Dossier A, Galicier L, Oksenhendler E, Boutboul D. Vanjak A, et al. Among authors: martin de fremont g. Br J Haematol. 2023 Apr;201(2):357-359. doi: 10.1111/bjh.18698. Epub 2023 Feb 14. Br J Haematol. 2023. PMID: 36786160 No abstract available.
Characteristics of circulating KSHV-infected viroblasts during active KSHV+ multicentric Castleman disease.
Martin de Frémont G, Vanjak A, Sbihi Z, Knapp S, Garzaro M, Chbihi M, Fournier B, Poirot J, Dossier A, Silvestrini MA, Villemonteix J, Meignin V, Galicier L, Bertinchamp R, Le Goff J, Salmona M, Flamarion E, Cassius C, Lebbé C, Ronchetti AM, Latour S, Oksenhendler E, Carcelain G, Boutboul D. Martin de Frémont G, et al. Blood Adv. 2023 May 9;7(9):1682-1691. doi: 10.1182/bloodadvances.2022008456. Blood Adv. 2023. PMID: 36508281 Free PMC article.
Myeloid Clonal Infiltrate Identified With Next-Generation Sequencing in Skin Lesions Associated With Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: A Case Series.
Martin de Frémont G, Hirsch P, Gimenez de Mestral S, Moguelet P, Ditchi Y, Emile JF, Senet P, Georgin-Lavialle S, Hanslik T, Maurier F, Adedjouma A, Abisror N, Mahevas T, Malard F, Adès L, Fenaux P, Fain O, Chasset F, Mekinian A. Martin de Frémont G, et al. Front Immunol. 2021 Oct 4;12:715053. doi: 10.3389/fimmu.2021.715053. eCollection 2021. Front Immunol. 2021. PMID: 34671345 Free PMC article.
20 results